Multi-stakeholder collaboration: the catalyst for innovation in kidney cancer care

March 31st 2021

Sponsored Content by Ipsen

Applying RxPONDER to Clinical Practice

March 30th 2021

Faculty from the Miami Breast Cancer Conference® discuss how to apply the RxPONDER data to clinical practice.

Keeping the Balance: Managing Therapy for Melanoma in the Adjuvant Setting During a Pandemic

January 26th 2021

More Can Be Done for Asian American Lung Cancer Patients

December 22nd 2020

The Role of Immunotherapy in Advancing Overall Survival for Metastatic Melanoma

December 17th 2020

Targeted Treatment Helps Delay ALK+ mNSCLC Progression

December 16th 2020

Remarkable progress has been made in the treatment of ALK+ mNSCLC patients, and the field continues to grow at a rapid pace.

Rethinking How We Approach Stage 3 Lung Cancer Treatment

October 20th 2020

As ongoing research continues to unlock the mechanisms of non–small cell lung cancer, it’s becoming increasingly clear that healthcare providers need to start rethinking how treatment is approached—especially for Stage 3 disease.

SPONSORED: Multidisciplinary Cancer Care Through Virtual Collaboration

September 28th 2020

How Genomic Testing and Targeted Therapies Are Shifting the Mindset for Treating Acute Myeloid Leukemia

September 18th 2020

Questions and answers with Dr. Eunice Wang, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, an unpaid Astellas consultant

Delivering Long-Term Results for Blood Cancer Patients

July 21st 2020

While great progress has been made in developing and delivering new treatment options for chronic lymphocytic leukemia, recognizing the chronic nature of the disease and being cognizant of side effects that can have a major impact on a patient’s quality of life remains an important responsibility.